Inventor

HALL FREDERICK L

US29 patents

⚠️ This page may combine multiple inventors who share the name “HALL FREDERICK L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

HALL FREDERICK L

UNIV SOUTHERN CALIFORNIA

Targeting pharmaceutical agents to injured tissues

Transgene delivering retrovirus targeting collagen exposed at site of tissue injury

Method of delivering therapeutic agents to site of tissue injury

Gene therapy methods using bone marrow-derived cells expressing blood clotting factors

Modified viral surface proteins for binding to extracellular matrix components

Matrix-targeted fusion polypeptides for tissue regeneration and wound healing

Targeted vectors for cancer immunotherapy

Mutated cyclin G1 protein

Factor 1X delivery method using bone marrow-derived cells

Targeting pharmaceutical agents to injured tissues

Methods and compositions for treating metastatic cancer

Identification of a pluripotent pre-mesenchymal, pre-hematopoietic progenitor cell

Expression of cyclin G1 in tumors

Osteogenic cell growth using a TGFβ1-von Willebrand&#39;s factor fusion protein

Retroviral vectors including modified envelope escort proteins

COUNTERPOINT BIOMEDICA LLC

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

Polypeptide targeting aptamers for characterization, capture, and clinical management of circulating tumor cells

Exposed collagen-targeted fusion cytokine for immune modulation in invasive cancers and lesions of infections

Targeting of pharmaceutical agents to pathologic areas using bifunctional fusion polypeptides

HALL FREDERICK L

Transgene delivering retrovirus targeting collagen exposed at site of tissue injury

Transgene delivering retrovirus targeting collagen exposed at site of tissue injury

Pathotropic targeted gene delivery system for cancer and other disorders

(unassigned)

Bone morphogenetic proteins and their use in bone growth

Artificial skin prepared from coclagen matrix containing transforming growth factor-β having a collagen binding site

DELTA NEXT GENE LLC

Cyclin G1 inhibitors and related methods of treating cancer

Cyclin G1 inhibitors and related methods of treating cancer

UNIV SOUTHERN CALIFORNIA UNIVE

TGFβ1 responsive bone marrow derived cells to express a recombinant protein

GORDON ERLINDA M

Targeted vectors for cancer immunotherapy

EPEIUS BIOTECHNOLOGIES

Transgene delivering retrovirus targeting collagen exposed at site of tissue injury

Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein